No image
Palonosetron 0.5mg
Product Overview
| Generic Name | Palonosetron 0.5mg |
| Brand Name(s) | Aloxi |
| Category | Antineoplastic / Cancer |
| Form | Oral Capsule |
| Strength | 0.5 mg |
| Therapeutic Class | 5-HT3 receptor antagonist, antiemetic |
| ATC Code | A04AA05 |
Manufacturing & Regulatory
| Manufacturer | Pfizer |
| GMP Compliance | WHO-GMP |
| DMF/CEP | Type II |
| COFEPRIS | Batch-specific |
| Free Sale Certificate | Yes |
Logistics & Export
| MOQ | 10 units |
| Shelf Life | 36 months |
| Storage | 15–30 °C |
| Incoterms | Ex-Works Mexico |
| Lead Time | 7 to 10 Days |
Documentation Available Upon Request
| Certificate of Analysis (PDF) | Yes |
| SDS-Safety Data Sheet (PDF) | Yes—for API and finished product |
| CTD Summary (PDF) | CTD from originator; generic use abbreviated formats |
Special Notes
Indications & Usage: Prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) and Prevention of postoperative nausea and vomiting (PONV)